US Map / Arizona
State AZ

Clinical Trials in Arizona

Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 242 actively recruiting studies with Arizona sites out of 242 registered in total. The busiest research areas in Arizona are Solid Tumor, Prostate Cancer, Obesity. Leading sponsors running trials in the state include Mayo Clinic, University of Arizona, AstraZeneca. By stage, Arizona trials break down as Phase 1 (37), Phase 2 (77), Phase 3 (80), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
242
Recruiting Now
242
← Back to US Map
Top Conditions in Arizona
Solid Tumor (6)Prostate Cancer (6)Obesity (6)Colorectal Cancer (4)Multiple Myeloma (3)Cancer (3)Advanced Solid Tumor (3)Developmental Language Disorder (3)Overweight (3)Colorectal Neoplasms (3)Carcinoma, Non-Small-Cell Lung (3)Graves' Disease (3)

Frequently Asked Questions — Clinical Trials in Arizona

How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 242 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 242. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Prostate Cancer, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Arizona

NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
View Trial →
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT07082738 Phase 2
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Ve...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
987 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT06750094 Phase 3
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in P...
Condition
Colorectal Neoplasms
Enrollment
700 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT06907966 N/A
Recruiting
Digital Support Strategies for Caregiver Home Practice
Condition
Acceptability
Enrollment
96 pts
Location
United States
Sponsor
Arizona State University
View Trial →
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT04558541 N/A
Recruiting
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequenti...
Condition
Developmental Language Disorder
Enrollment
400 pts
Location
United States
Sponsor
Father Flanagan's Boys' Home
View Trial →
NCT07047144 Phase 2
Recruiting
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years ...
Condition
Spinal Muscular Atrophy
Enrollment
52 pts
Location
United States, Belgium, France
Sponsor
Scholar Rock, Inc.
View Trial →
NCT06252649 Phase 3
Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevac...
Condition
Metastatic Colorectal Cancer
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT05911568 N/A
Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disab...
Condition
Stroke
Enrollment
1,060 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
View Trial →
NCT07507422 N/A
Recruiting
Post Market Evaluation of Real World Outcomes and Durability to Support Implanta...
Condition
Chronic Pain
Enrollment
970 pts
Location
United States, Belgium, France
Sponsor
Medtronic
View Trial →
NCT07286305 N/A
Recruiting
Media and Mental Health
Condition
Mental and Behavioral Disorders
Enrollment
70 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT06994806 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in C...
Condition
Solid Tumor Malignancies
Enrollment
84 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
View Trial →
NCT06765668 Phase 4
Recruiting
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Partici...
Condition
Parkinson Disease
Enrollment
220 pts
Location
United States
Sponsor
Impax Laboratories, LLC
View Trial →
NCT06976268 Phase 2, Phase 3
Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment...
Condition
Parkinson Disease
Enrollment
550 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
View Trial →
NCT07464860 N/A
Recruiting
Feasibility of Breathwork Intervention With Older Adults After Knee Surgery
Condition
Surgical Stress Response
Enrollment
32 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT06562543 Phase 4
Recruiting
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populati...
Condition
Colorectal Cancer
Enrollment
78 pts
Location
United States, Puerto Rico
Sponsor
Takeda
View Trial →
NCT04862468 Phase 2
Recruiting
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thro...
Condition
Thrombosis, Deep Vein
Enrollment
80 pts
Location
United States, Ireland, United Kingdom
Sponsor
Mercator MedSystems, Inc.
View Trial →
NCT05868226 Phase 1, Phase 2
Recruiting
PRE-ISPY Phase I/II Oncology Platform Program
Condition
HER2-positive Breast Cancer
Enrollment
280 pts
Location
United States
Sponsor
QuantumLeap Healthcare Collabo
View Trial →
NCT07623135 Phase 3
Recruiting
Lumateperone for Late-Life Depression
Condition
Treatment Resistant Depression (TRD)
Enrollment
100 pts
Location
United States
Sponsor
Eric Lenze
View Trial →
NCT07009210 N/A
Recruiting
AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients Wit...
Condition
Serious Illness
Enrollment
20 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT07502443 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolep...
Condition
Narcolepsy Type 2
Enrollment
176 pts
Location
United States, Australia, Belgium
Sponsor
Alkermes, Inc.
View Trial →
NCT06843317 Phase 1
Recruiting
Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adult...
Condition
RSV Infection
Enrollment
160 pts
Location
United States
Sponsor
Clover Biopharmaceuticals USA,
View Trial →
Page 4 of 10 — 242 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology